Sign in
4

Changes in Ownership

Prime Medicine, Inc. Filed Acc 0001894562-25-000012

Options or other derivatives

  • See Remarks acquired 90,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Alenson Carman See Remarks 2025-02-27 Grant or award · Stock Option (right to buy) +90,500 90,500 D
Loading xslF345X05/wk-form4_1741051100.xml…